4//SEC Filing
Marguglio David J. 4
Accession 0001593968-20-002228
CIK 0000887247other
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 4:31 PM ET
Size
6.5 KB
Accession
0001593968-20-002228
Insider Transaction Report
Form 4
Marguglio David J.
Director
Transactions
- Sale
Common Stock
2020-11-18$0.41/sh−8,532$3,465→ 322,264 total
Holdings
- 5,884(indirect: By Children)
Common Stock
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The shares were sold to satisfy the withholding and tax obligations relating to the issuance of shares upon the vesting of RSUs previously granted to the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.4025 to $0.408, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]Includes shares of common stock beneficially owned and shares of common stock issuable upon vesting of restricted stock units previously reported in Table 1 of Form 4.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeother
Related Parties
1- filerCIK 0001461753
Filing Metadata
- Form type
- 4
- Filed
- Nov 19, 7:00 PM ET
- Accepted
- Nov 20, 4:31 PM ET
- Size
- 6.5 KB